Divergent Trends for Two Leading Weight Loss Drugs! Strong Sales Ignite Eli Lilly's (LLY.US) Q2 Outperformance
智通财经2026/08/05 12:56Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
智通财经APP reported that Eli Lilly (LLY.US) announced second-quarter results before the market opened on Wednesday that exceeded market expectations, mainly due to strong sales of its injectable GLP-1 drug and its newly launched oral weight-loss drug Foundayo. As of press time, the company's shares are up 5%.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Crypto prices
More
Bitcoin
BTC
$80,435.84
+0.70%
Ethereum
ETH
$2,524.71
+1.71%
Tether USDt
USDT
$0.9999
-0.02%
BNB
BNB
$754.04
-1.63%
XRP
XRP
$1.42
+0.78%
USDC
USDC
$0.9999
-0.00%
Solana
SOL
$106.68
+3.33%
TRON
TRX
$0.3356
+0.47%
Hyperliquid
HYPE
$87.82
+2.99%
Zcash
ZEC
$1,227.24
+19.84%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now